Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mayu, Kimura"'
Publikováno v:
Journal of Water and Environment Technology, Vol 22, Iss 2, Pp 92-99 (2024)
Invasive alien species Alternanthera philoxeroides was found on Lake Biwa shore for almost two decades and has been causing huge loss for this region. This study aims at investigating three impact factors on reproduction of A. philoxeroides, namely n
Externí odkaz:
https://doaj.org/article/ef58eac4b2f447b89efe78914bd35a5d
Publikováno v:
Journal of Veterinary Medical Science; 2024, Vol. 86 Issue 8, p885-891, 7p
Autor:
Musashi Kawamura, Naoki Goda, Natsuyo Hariya, Mayu Kimura, Shiori Ishiyama, Takeo Kubota, Kazuki Mochizuki
Publikováno v:
Biochemistry and Biophysics Reports, Vol 29, Iss , Pp 101196- (2022)
Background: The expressions of genes related to lipid metabolism are decreased in adipocytes with insulin resistance. In this study, we examined the effects of fatty acids on the reduced expressions and histone acetylation of lipid metabolism-related
Externí odkaz:
https://doaj.org/article/9fd0453fd3444a699fa0adb7825fa65f
Autor:
Shiori Ishiyama, Mayu Kimura, Takao Nakagawa, Yuka Fujimoto, Kohei Uchimura, Satoshi Kishigami, Kazuki Mochizuki
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Diabetic kidney disease (DKD) is a critical complication associated with diabetes; however, there are only a few animal models that can be used to explore its pathogenesis. In the present study, we established a mouse model of DKD using a technique b
Externí odkaz:
https://doaj.org/article/9460dd808d4f465080629a3c1920e000
Autor:
Shiori Ishiyama, Mayu Kimura, Nodoka Umihira, Sachi Matsumoto, Atsushi Takahashi, Takao Nakagawa, Teruhiko Wakayama, Satoshi Kishigami, Kazuki Mochizuki
Publikováno v:
Biochemistry and Biophysics Reports, Vol 27, Iss , Pp 101029- (2021)
Non-alcoholic fatty liver disease (NAFLD), which includes the subtype non-alcoholic steatohepatitis (NASH), is a major complication of type 2 diabetic mellitus (T2DM), even among non-obese patients. However, the exact cause of NAFLD/NASH in non-obese
Externí odkaz:
https://doaj.org/article/9a8f623cedc2435e95b4d93cac5dd179
Publikováno v:
ACS Food Science & Technology. 1:993-1001
Publikováno v:
Veterinary and Comparative Oncology. 19:34-43
Anti-angiogenic therapy is a cancer treatment strategy targeting new blood vessel formation. Microvessel density (MVD) is a histopathological method for evaluating angiogenesis and endoglin is used as an activated endothelial marker in human medicine
Publikováno v:
The Journal of veterinary medical science. 84(1)
The vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) signaling pathway plays an important role in tumor angiogenesis. VEGFR2 is expressed not only in vascular endothelial cells but also in tumor cells; however, the relationship of V
Autor:
Kazuki Mochizuki, Atsushi Takahashi, Shiori Ishiyama, Nodoka Umihira, Teruhiko Wakayama, Mayu Kimura, Sachi Matsumoto, Satoshi Kishigami, Takao Nakagawa
Publikováno v:
Biochemistry and Biophysics Reports, Vol 27, Iss, Pp 101029-(2021)
Non-alcoholic fatty liver disease (NAFLD), which includes the subtype non-alcoholic steatohepatitis (NASH), is a major complication of type 2 diabetic mellitus (T2DM), even among non-obese patients. However, the exact cause of NAFLD/NASH in non-obese
Publikováno v:
The Proceedings of the Annual Convention of the Japanese Psychological Association. 83:3A-048